These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11394440)

  • 1. Negative regulation of Janus kinases.
    Duhé RJ; Wang LH; Farrar WL
    Cell Biochem Biophys; 2001; 34(1):17-59. PubMed ID: 11394440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Janus kinases: components of multiple signaling pathways.
    Rane SG; Reddy EP
    Oncogene; 2000 Nov; 19(49):5662-79. PubMed ID: 11114747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.
    Reddy EP; Korapati A; Chaturvedi P; Rane S
    Oncogene; 2000 May; 19(21):2532-47. PubMed ID: 10851052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.
    Nosaka T; Kitamura T
    Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.
    Sasaki A; Yasukawa H; Suzuki A; Kamizono S; Syoda T; Kinjyo I; Sasaki M; Johnston JA; Yoshimura A
    Genes Cells; 1999 Jun; 4(6):339-51. PubMed ID: 10421843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
    Valentino L; Pierre J
    Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK protein kinase inhibitors.
    Thompson JE
    Drug News Perspect; 2005 Jun; 18(5):305-10. PubMed ID: 16193102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Janus protein tyrosine kinases in hematopoietic cytokine signaling.
    Ihle JN
    Semin Immunol; 1995 Aug; 7(4):247-54. PubMed ID: 8520029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-regulation of JAK and Src kinases.
    Ingley E; Klinken SP
    Growth Factors; 2006 Mar; 24(1):89-95. PubMed ID: 16393697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Janus kinases in haemopoiesis and haematological malignancy.
    Khwaja A
    Br J Haematol; 2006 Aug; 134(4):366-84. PubMed ID: 16822289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine signal transduction and the JAK family of protein tyrosine kinases.
    Wilks AF; Harpur AG
    Bioessays; 1994 May; 16(5):313-20. PubMed ID: 8024540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAKs, STATs and Src kinases in hematopoiesis.
    Rane SG; Reddy EP
    Oncogene; 2002 May; 21(21):3334-58. PubMed ID: 12032773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Janus kinases in cytokine signalling.
    Ihle JN
    Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):159-66. PubMed ID: 8650262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK/STAT-dependent gene regulation by cytokines.
    Hebenstreit D; Horejs-Hoeck J; Duschl A
    Drug News Perspect; 2005 May; 18(4):243-9. PubMed ID: 16034480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new protein containing an SH2 domain that inhibits JAK kinases.
    Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
    Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes.
    DeVito WJ; Stone S
    J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Janus kinase 2 by cisplatin in cancer cells.
    Song H; Sondak VK; Barber DL; Reid TJ; Lin J
    Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.